The mean scores for total VHI and functional, physical, and emotional functioning domain subscales were found to be significantly higher in LPR patients versus controls (P < .0001), with no difference among LPR subgroups. Abnormal anxiety was one third in both LPR subgroups versus 6.4% of controls (P < .001). Both LPR subgroups patients had significantly reduced social activities and significantly lower mean W-B VAS score than controls. LPR symptoms had a significant relation with all tested QL parameters, whereas laryngoscopic findings had a significant relation with VHI and W-B VAS only. All mean QL parameters scores improved after 3-month omeprazole treatment. Conclusions: QL in LPR patients with or without esophagitis is impaired significantly in many aspects. Impairment of QL is more associated with symptoms than laryngoscopic findings. Treatment with omeprazole significantly improved QL in both LPR subgroups patients. Key Words: Laryngopharyngeal reflux, health-related quality of life, voice handicap index, hospital anxiety and depression scale.
INTRODUCTION
Laryngopharyngeal reflux (LPR) is a gastrointestinal (GI) and otolaryngologic condition related to but distinct from gastroesophageal reflux disease (GERD). 1 LPR refers to the backflow of stomach contents into the throat and larynx with presentation of symptoms of chronic dysphonia, throat clearing, cough, globus sensation, and sore throat. Signs of laryngeal irritation are present with or without granulation. 1, 2 The incidence of typical heartburn in patients with LPR has been reported up to 50% and esophagitis approximately 25%. 1 One hypothesis to explain the low incidence of heartburn and erosive esophagitis is that the laryngopharyngeal epithelium is more sensitive to reflux-related injury than esophageal epithelium. Therefore, smaller amounts of reflux are capable of causing damage. 3 On the basis of recent investigations, some authors believe that LPR and GERD are not totally different entities of reflux disease but rather represent different entities of reflux disease. 3, 4 It is important to note that although most patients with LPR do not have GERD, some patients do indeed have both LPR and GERD. 1 Evidence indicates that combined reflux is associated with a more severe disease expression. 4 Health-related quality of life (QL) has been studied for many diseases, including GI disorders. 5 Recent studies showed that heartburn substantially impairs all aspects of health-related QL. 5, 6 Treatment and adequate symptom control improved the QL. 7 Health-related QL can be measured with generic or disease-specific questionnaires, [5] [6] [7] and other instruments have been used to evaluate the impact of voice disorders. 8 However, the QL impact of LPR has only recently begun to be evaluated and is not well understood. 7, 9, 10, 11 The aims of this study were to evaluate and compare QL parameters in patients with LPR versus healthy controls, to determine the impact of clinical signs to QL, and to assess changes in QL parameters after treatment.
MATERIALS AND METHODS
One hundred thirty-six adult outpatients with newly suspected LPR on the basis of chronic (lasting more than 1 month) laryngeal symptoms commonly associated with LPR, hoarseness, throat clearing, globus sensation, sore throat, and cough with typical laryngeal findings of reflux laryngitis (erythema, edema, hypertrophy of posterior glottis, vocal fold edema, subglottic edema) were evaluated. To be eligible, patients were required to have 1) at least two laryngeal symptoms rated not less than 2 points on 0 to 3 Likert severity scale and 2) at least posterior laryngitis after exclusion of all other possible cases of laryngeal inflammation (i.e., allergy, voice abuse, infection, sinus pathology, asthma, and active smoking). The presence of heartburn was not a requirement for inclusion in the study. Subjects were excluded if they met the following criteria: additional laryngeal findings such as nodule, polyp, cyst, neoplasms, prior antireflux surgery, upper tract infections in the last month, pregnancy during study period, and diagnosed psychiatric illness. The next step diagnosis of clinically suspected LPR patients was confirmed by two tests: 11 1) by positive response of symptoms to a 3-month treatment with omeprazole or by 2) endoscopic observation of mucosal injury not less than A grade esophagitis on Los Angeles classification 12 during upper GI endoscopy. Eligible subjects passing all exclusion criteria then completed questionnaires, video laryngoscopy, and upper GI endoscopy. After completion, all patients were treated with omeprazole for 3 months. First-month patients were randomized to receive omeprazole 20 mg once daily or 20 mg twice daily in a 1:2.5 ratio. During the next 2 months, all patients received omeprazole 20 mg twice daily. All patients tolerated treatment well and no additional medication and no special orders to change habits were given. Finally, after complete examination, 100 of the evaluated 136 patients were selected. All selected patients responded to a 3 month standard dose of omeprazole. Patients were considered to be responders if they had a reduction of at least 50% in their self-rated symptom score and patients were satisfied with the results (rating: very satisfied, satisfied). 13 Erosive esophagitis was confirmed for 21 of these 100 patients (17 of them had esophagitis A and 4 esophagitis B). LPR patients were stratified into two subgroups: LPR patients without esophagitis (n ϭ 79) and LPR patients with esophagitis (n ϭ 21).
The control group consisted of 109 asymptomatic persons without otolaryngologic problems, healthy voice during examination, and no organic pathology on the vocal folds. They were randomly selected from volunteers aged 20 to 67 years. Study was conducted at Kaunas Medical University Hospital, Lithuania. Written informed consent was obtained from all participants. The protocol was approved by yjr Ethical Committee of Kaunas University of Medicine.
Symptoms. Each laryngeal symptom (i.e., hoarseness, throat clearing, globus sensation, sore throat, chronic cough, and heartburn) were rated using a 4-point Likert scale: 0, no symptom; and 3, severe symptoms (hard to tolerate, interfered with planned activities). The sum of the symptom severity score multiplied by the number of presenting symptoms composed the laryngeal and esophageal score (sum of both for total score of 0 -78 points).
Videolaryngoscopy. Telescopic videolaryngoscopies with a Kay Elemetrics 70°endoscope (Lincoln Park, NJ)) were performed by the first author. Laryngeal abnormalities of four laryngeal regions (posterior, vocal folds, vestibular folds, and subglottic area) were evaluated, with each region receiving a rating on color, edema, and hypertrophy using a 4-point Likert scale: 0, no sign; 3 severe signs. The sum of the separate region scores composed a total grade (0 -36 points). More than a 2-point score considered was as positive for posterior laryngitis. Rating of video recordings from VHS was blinded to the patients groups and controls. Patients who exhibited mostly posterior laryngeal region inflammation or mild vocal fold edema were considered to have minor LPR. 2 
Quality of Life Assessment
Voice handicap index. The 30-item voice handicap index (VHI) measures the impact of voice problems on a person's life. 8 Subjects rate each statement on 5-point, equal-appearing scale, with the following values: 0 as never and 4 as always. The VHI generates a total score (ranging from 0 -120) and three subscale scores: functional, physical, and emotional.
Hospital anxiety and depression scale. The hospital anxiety and depression scale (HAD) is a self-assessment scale designed to detect psychologic distress in physically ill patients. 14 The questionnaire consists of 14 items with four response categories, measuring the levels of anxiety and depression in two separate subscales. Scale scores range from 0, no symptoms, to 21, maximum of distress. Scores 11 or greater in either of the subscales indicate probable psychologic distress.
Disability in social activities. Disease influence on social activities was self-rated by the subjects on a 7-point Likert frequency scale (1, always; 7, never).
Well-being in general (W-B VAS ) was self-rated using a 100 mm visual analogue scale: 0, extremely bad; 100, excellent. One millimeter measured by rule is equal to 1 point; 0 to 70 points were considered as severe to moderate damage.
Statistical Methods
Statistical analysis was performed with SPSS 10 for Windows (SPSS Corp., Chicago, IL). Nonparametric Mann-Whitney U test was used for not normally distributed quantitative parameters, and for nonparametric data, a t test for normally distributed quantitative parameters was used. Multiple comparisons between groups were assessed using an analysis of variance model; the significance level was adjusted by using a Bonferroni inequality. A paired t test was used to test the difference of QL parameters in repeated measures. A chi-square test was used to compare proportions. Correlation analysis was made with Pearson correlation coefficient (r). A level of significance of .05 was used.
RESULTS

Subjects characteristics.
The subgroup of LPR patients without esophagitis consisted of 20 (25.3%) males and 59 (74.7%) females with mean age of 38.8 Ϯ 14.5 years; the subgroup of LPR patients with esophagitis consisted of 5 (23.8%) males and 16 (76.2%) females with mean age of 43.8 Ϯ 9.9 years. The control group subjects included 26 (23.8%) males and 83 (76.2%) females with mean age of 36.4 Ϯ 10.9 years. LPR subgroups and control group subjects did not significantly differ with regard to age, sex proportion, smoking history, and voice training.
Clinical characteristics of investigated groups are presented in Table I . Patients reported multiple symptoms of LPR on clinical presentation. LPR patients with esophagitis showed significantly higher heartburn rate compared with LPR patients without esophagitis (P ϭ .036). Moderate symptom severity was predominant in both LPR subgroups. Occurrence of each symptom and the median scores of severity were significantly higher for both LPR subgroups versus controls (P Ͻ .0001). Eighty-three percent of patients had mild to moderate laryngoscopic findings. Eleven patients were considered to have only posterior laryngitis, and 63 patients had mild vocal fold edema with no significant difference among LPR subgroups. LPR patients and controls differed significantly with respect to all tested regions of the larynx (P Ͻ .0001). Table II .
Voice handicap index. The mean scores of total, functional, physical, and emotional functioning domain subscales for VHI were found to be significantly higher in both LPR subgroup patients versus healthy controls (P Ͻ .0001). No statistically significant difference was found among LPR subgroups. Both LPR subgroup patients showed worse results on the physical VHI subscale (12.6 Ϯ 8.5 and 12.6 Ϯ 8.5) than on the functional, (6.9 Ϯ 6.8 and 7.8 Ϯ 8.1) and emotional (7.3 Ϯ 7.1 and 7.1 Ϯ 7.8).
Hospital anxiety and depression scale. Abnormal anxiety (Ն11 points) scores were equally obtained for both LPR subgroups patients: in 30.4% of LPR patients without esophagitis and in 28.6% of LPR patients with esophagitis (P Ͼ .05) versus 6.4% of controls (P Ͻ .0001). Depression was stated for 6.3% LPR patients without esophagitis and 9.5% with esophagitis versus 1.8% for controls (P Ͼ .05).
The mean scores of both HAD subscales were significantly higher in LPR patients than those for controls (P Ͻ .001) Disability in social activities. LPR patients without or with esophagitis had significantly more reduced scores in social activities (ratings from 1, always, to 4, on occasion) in comparison with controls, 33.0% and 47.6% versus 8.2% (P Ͻ .05).
Well-being in general. The percentage of LPR patients without esophagitis was 84.8%, and 90.5% of patients with esophagitis W-B VAS were rated as moderately to severely damaged. Both LPR subgroups patients rated significantly lower mean W-B VAS scores compared with controls (P Ͻ .0001).
Correlation of symptoms and QL parameters. LPR patients without esophagitis showed a moderately significant correlation of hoarseness and VHI (r ϭ 0.54, P Ͻ .0001), chronic cough with HAD (r ϭ 0.23, P ϭ .045), and W-B VAS (r ϭ -0.32, P ϭ .004). LPR patients with esophagitis showed significant correlation with throat clearing (HAD r ϭ 0.46, P ϭ .048, W-B VAS r ϭ 0.64, P ϭ .003), chronic cough with HAD (r ϭ 0.23, P ϭ .045), and disability in social activities (r ϭ 0.67, P ϭ .001). Heartburn had a moderately significant relation with HAD and disability in the social activities scales in LPR patients with esophagitis.
Correlation of laryngoscopic findings and QL parameters. LPR patients without esophagitis showed a mildly significant relation between vestibular fold score and VHI (r ϭ 0.27, P ϭ .017) and moderate vocal fold score and W-B VAS (r ϭ -0.31, P ϭ .006), whereas LPR patients with esophagitis only showed a moderate relation between vocal fold score and VHI (r ϭ 0.6, P ϭ .001).
Changes of QL parameters scores after PPI treatment. After 3-month omeprazole treatment, both LPR subgroups patients showed improvement on QL parameters scores. Mean changes of almost all tested QL parameters, except depression score, were statistically significant (P Ͻ .0001). Analysis of separate subgroups demonstrated the same results in LPR patients without esophagitis and significant positive changes for disability in social activities and W-B VAS in LPR patients with esophagitis (Table III) . After 3-month treatment, normalization in psychologic status (HAD scale), social activities, and W-B VAS was found in both LPR subgroups. Only mean VHI score in LPR patients differed significantly from controls (P Ͻ .001).
DISCUSSION
Some recent investigations have tested the differences between LPR and GERD QL. 10, 15 Powitzky et al. 15 reported that patients with clinically diagnosed LPR have worse scores on VHI than do patients with GERD, and Carrau et al. 9 established that patients with LPR report significantly lower scores than patients with GERD in the domains of vitality and social functioning.
Patients enrolled in this study had primary symptoms of LPR seeking otorhinolaryngologic help. In accordance with the literature, 21% of these patients had erosive esophagitis along with LPR, thus forming a subgroup. 1 Although LPR patients with esophagitis showed some differences in symptom expression, no statistically significant difference was found on all tested QL parameters. Hoarseness was prevalent in both LPR subgroups, with 84.7% and 85.7%. This finding was corroborated by the mean VHI scores that were significantly higher than those for the healthy controls and were similar to values reported by previous investigators. 7, 15 Although most of our study patients were not professional voice users, up to 77% of LPR patients had significantly decreased social activities compared with healthy controls. Our data show that both LPR subgroup patients had significant increase in psychologic distress, with more anxiety in comparison with healthy controls. One third of LPR patients were anxious versus 6.4% of controls. One study with GERD patients showed similar results on the HAD scale: 8% of the heartburn patients were depressed, and one fourth were anxious. 6 This was not a surprising finding considering the chronic nature of the symptoms as well as difficulties in LPR diagnosis that may affect patients' emotional status. Also, more anxiety in LPR may in part be a result of patients concern about laryngeal cancer. Their primary esophageal symptoms have an impact on QL because patients with GERD are stressed because of possible underlying serious disease. 13 All of the abovementioned effects on QL lead to impaired W-B VAS . This parameter was found almost twofold less in LPR patients than in healthy controls. W-B VAS was rated as moderately to severely damaged in more than 84% of both LPR subgroups. This finding is in accordance with previous studies with patients who had untreated GERD. QL was worse than that of patients with other chronic disease such as diabetes or hypertension. 10 Correlation analysis showed that LPR symptoms had more a obvious impact on QL parameters in LPR patients with or without esophagitis than objective findings. LPR symptoms had a significant correlation with all tested QL parameters, whereas laryngoscopic findings only had correlation with VHI and W-B VAS . LPR patients without esophagitis suffered a major impact on QL with hoarseness and chronic cough, and LPR patients with esophagitis had more severe throat clearing, chronic cough, sore throat, and heartburn. All LPR patients demonstrated vocal fold injury that impacted on QL parameters. These findings provide information that shows that, despite minor laryngoscopic findings, QL impairment generally appeared in clinical practice and was estimated in 74 of 100 our study patients. QL in patients with LPR is impaired significantly, irrespective of whether the patients presented with or without esophagitis. Previous studies have shown that despite subtle and nonspecific laryngoscopic findings, patients may have intensive symptoms that indicate LPR. 2, 15 This study confirmed that effective treatment with relief of symptoms improved LPR patients QL in all aspects.
Normalization of QL parameters after treatment was achieved in almost all QL parameters except VHI. Probably, a longer treatment period may be needed for this parameter to be normalized in addition to factors being taken into account such as vocal hygiene. Some differences between subgroup data indicate that LPR patients with esophagitis showed less improvement in HAD and VHI scores, and this could be influenced by the relatively small subgroup size (n ϭ 21).
Criticism of our study could be made because of the relatively small sample of LPR patients with esophagitis when LPR patients were divided into the two subgroups and when diagnosis was made without pH monitoring. To diagnose LPR, we followed the accepted recommendations. 1, 11 We consider patients with erosive esophagitis as a solid basis to confirm diagnosis.
In summary, we recommend that physicians ask patients about and test them on the impact of LPR on their lives and emotional status and set treatment goals according to the established context. QL measures may provide useful information in choosing treatment strategies. Symptomatic LPR patients, even those with minor laryngoscopic findings, should be treated with the most effective medicines, such as proton pump inhibitors. This could ensure cost-effective treatment, LPR symptoms relief, and better QL. Further research is needed for the selection of the most valuable QL parameters to be tested for in LPR patients.
CONCLUSIONS
QL in patients with LPR is impaired equally significantly in many aspects for patients without or with esophagitis. LPR patients showed significantly worse mean VHI scores compared with controls. One third of LPR patients suffered from anxiety and significantly reduced social activities as well as significantly lower mean W-B VAS scores compared with controls. Correlation analysis showed symptoms have more impact on QL than laryngoscopic findings and were similar for both LPR subgroups. LPR symptoms had a significant correlation with all tested QL parameters: VHI, HAD, social activities, and W-B VAS , whereas laryngoscopic findings had only mild to moderate correlation. Treatment with omeprazole significantly improved QL irrespective of whether the LPR patients presented with or without esophagitis.
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